Nichols Weston's Form 4 filing
Cullinan Therapeutics, Inc. (CGEM) · filed Oct 10, 2025
- Accession no.
- 0000902664-25-004379
- Filed
- Oct 10, 2025, 6:58 PM ET
- Trade date
- Oct 8-10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $9.83M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nichols WestonCIK 0001746376 | 10% Owner |
| Lynx1 Capital Management LPCIK 0001910456 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | Common stock, $0.0001 par value per share ("Common Stock") | PPurchaseAcquired | +556,300 | $6.46 | +$3,593,698 | 7,645,743 | Indirect | |
| Oct 9, 2025 | Common Stock | PPurchaseAcquired | +626,043 | $6.70 | +$4,191,858.72 | 8,271,786 | Indirect | |
| Oct 10, 2025 | Common Stock | PPurchaseAcquired | +277,298 | $7.36 | +$2,041,384.69 | 8,549,084 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.